In vitro treatment of tumor cells with CBL0137 resulted in FACT binding to chromatin as evidenced by SSRP1 loss from the soluble fraction and accumulation within the chromatin pellet in treated samples (Figure 3B). The gene discussed is SSRP1; the disease is neoplasm.